Literature DB >> 35793659

Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer.

Daniel Q Huang1, Amit G Singal2, Yuko Kono3, Darren J H Tan4, Hashem B El-Serag5, Rohit Loomba6.   

Abstract

Liver cancer epidemiology is changing due to increasing alcohol consumption, rising prevalence of obesity, and advances in hepatitis B virus (HBV) and hepatitis C virus (HCV) treatment. However, the impact of these changes on global liver cancer burden remains unclear. We estimated global and regional temporal trends in the burden of liver cancer and the contributions of various liver disease etiologies using the methodology framework of the Global Burden of Disease study. Between 2010 and 2019, there was a 25% increase in liver cancer deaths. Age-standardized death rates (ASDRs) increased only in the Americas and remained stable or fell in all other regions. Between 2010 and 2019, non-alcoholic steatohepatitis (NASH) and alcohol had the fastest growing ASDRs, while HCV and HBV declined. Urgent measures are required at a global level to tackle underlying metabolic risk factors and slow the growing burden of NASH-associated liver cancer, especially in the Americas.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  alcohol; epidemiology; etiology; hepatitis B; hepatitis C; hepatocellular carcinoma; hepatoma; liver cancer; nonalcoholic steatohepatitis

Mesh:

Year:  2022        PMID: 35793659     DOI: 10.1016/j.cmet.2022.05.003

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   31.373


  5 in total

1.  The growing threat of non-alcoholic fatty liver disease-related hepatocellular carcinoma.

Authors:  Margaret L P Teng; Kai En Chan; Darren J H Tan; Daniel Q Huang
Journal:  Hepatobiliary Surg Nutr       Date:  2022-10       Impact factor: 8.265

Review 2.  Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors.

Authors:  Daniel Q Huang; Philippe Mathurin; Helena Cortez-Pinto; Rohit Loomba
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-10-18       Impact factor: 73.082

3.  Modulating hepatic macrophages with annexin A1 in non-alcoholic steatohepatitis.

Authors:  Federico F De Ponti; Charlotte L Scott
Journal:  Clin Sci (Lond)       Date:  2022-08-12       Impact factor: 6.876

Review 4.  Obesity Management in the Primary Prevention of Hepatocellular Carcinoma.

Authors:  Elizabeth R M Zunica; Elizabeth C Heintz; Christopher L Axelrod; John P Kirwan
Journal:  Cancers (Basel)       Date:  2022-08-22       Impact factor: 6.575

5.  Alarming increase of NASH as cause of liver cancer.

Authors:  Ana Craciun; Helena Cortez-Pinto
Journal:  Cell Rep Med       Date:  2022-08-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.